Evidence map›Paper›PMID 33597026›Full record

ArticleMicrobiome2021

PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic data.

Laura de Nies, Sara Lopes, Susheel Bhanu Busi, Valentina Galata, Anna Heintz-Buschart, Cedric Christian Laczny, Patrick May, Paul Wilmes

Abstract readVideo-Audio Media
In one paragraph

Article in Microbiome, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Antibiotic resistance inFrontiers in microbiology · 2026
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laura de NiesSystems Ecology Research Group, Luxembourg Centre for Systems Biomedicine, Esch-sur-Alzette, Luxembourg.
Sara LopesSystems Ecology Research Group, Luxembourg Centre for Systems Biomedicine, Esch-sur-Alzette, Luxembourg.
Susheel Bhanu BusiSystems Ecology Research Group, Luxembourg Centre for Systems Biomedicine, Esch-sur-Alzette, Luxembourg.
Valentina GalataSystems Ecology Research Group, Luxembourg Centre for Systems Biomedicine, Esch-sur-Alzette, Luxembourg.
Anna Heintz-BuschartSystems Ecology Research Group, Luxembourg Centre for Systems Biomedicine, Esch-sur-Alzette, Luxembourg.
Cedric Christian LacznySystems Ecology Research Group, Luxembourg Centre for Systems Biomedicine, Esch-sur-Alzette, Luxembourg.
Patrick MayBioinformatics Core, Luxembourg Centre for Systems Biomedicine, Esch-sur-Alzette, Luxembourg.
Paul WilmesSystems Ecology Research Group, Luxembourg Centre for Systems Biomedicine, Esch-sur-Alzette, Luxembourg. paul.wilmes@uni.lu.ORCID 0000-0002-6478-2924

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPathogenic microorganisms cause disease by invading, colonizing, and damaging their host. Virulence factors including bacterial toxins contribute to pathogenicity. Additionally, antimicrobial resistance genes allow pathogens to evade otherwise curative treatments. To understand causal relationships between microbiome compositions, functioning, and disease, it is essential to identify virulence factors and antimicrobial resistance genes in situ. At present, there is a clear lack of computational approaches to simultaneously identify these factors in metagenomic datasets.

resultsHere, we present PathoFact, a tool for the contextualized prediction of virulence factors, bacterial toxins, and antimicrobial resistance genes with high accuracy (0.921, 0.832 and 0.979, respectively) and specificity (0.957, 0.989 and 0.994). We evaluate the performance of PathoFact on simulated metagenomic datasets and perform a comparison to two other general workflows for the analysis of metagenomic data. PathoFact outperforms all existing workflows in predicting virulence factors and toxin genes. It performs comparably to one pipeline regarding the prediction of antimicrobial resistance while outperforming the others. We further demonstrate the performance of PathoFact on three publicly available case-control metagenomic datasets representing an actual infection as well as chronic diseases in which either pathogenic potential or bacterial toxins are hypothesized to play a role. In each case, we identify virulence factors and AMR genes which differentiated between the case and control groups, thereby revealing novel gene associations with the studied diseases.

conclusionPathoFact is an easy-to-use, modular, and reproducible pipeline for the identification of virulence factors, bacterial toxins, and antimicrobial resistance genes in metagenomic data. Additionally, our tool combines the prediction of these pathogenicity factors with the identification of mobile genetic elements. This provides further depth to the analysis by considering the genomic context of the pertinent genes. Furthermore, PathoFact's modules for virulence factors, toxins, and antimicrobial resistance genes can be applied independently, thereby making it a flexible and versatile tool. PathoFact, its models, and databases are freely available at https://pathofact.lcsb.uni.lu . Video abstract.

Indexed as

MetagenomicsSoftwareAnti-Bacterial AgentsAnti-Infective AgentsDrug Resistance, BacterialVirulence FactorsAnti-Bacterial AgentsAnti-Infective AgentsVirulence FactorsAntimicrobial resistanceBacterial toxinsBioinformaticsMetagenomicsMicrobiomeMobile genetic elementsVirulence factors

Identifiers

PMID33597026
PMCPMC7890817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.